ANIMAL STUDIES ON THE ROLE OF 50 60-HERTZ MAGNETIC-FIELDS IN CARCINOGENESIS/

Citation
W. Loscher et M. Mevissen, ANIMAL STUDIES ON THE ROLE OF 50 60-HERTZ MAGNETIC-FIELDS IN CARCINOGENESIS/, Life sciences, 54(21), 1994, pp. 1531-1543
Citations number
67
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
Journal title
ISSN journal
00243205
Volume
54
Issue
21
Year of publication
1994
Pages
1531 - 1543
Database
ISI
SICI code
0024-3205(1994)54:21<1531:ASOTRO>2.0.ZU;2-8
Abstract
A number of epidemiological studies have suggested that exposure to 50 /60-Hz magnetic fields (MF) from power lines and electrical equipment may be associated with a modestly increased incidence of various types of cancer. Laboratory studies have indicated that nonionizing radiati on has no mutagenic effect, i.e. does not initiate cancer. Thus, if 50 /60-Hz MF are truly associated with an increased risk of cancer, then these fields must act as a promoter or co-promoter of cancer in cells that have already been initiated. This paper reviews the evidence prod uced by animal studies. As shown in this review, the available animal data on 50/60-Hz MF exposures seem to indicate that intermediate MF ex posure exerts co-promoting effects in different tumor models, particul arly cocarcinogenesis models of breast cancer, while chronic (up to li fe-time) exposure may exert promoting effects on ''spontaneous'' devel opment of certain tumors. The tumor promoting or co-promoting effects of 50/60-Hz MF exposure found in several animal studies could relate t o actions of MF on gene expression, immune surveillance, and Ca2+ home ostasis as demonstrated by in vitro experiments in cell cultures. Howe ver, the most plausible evidence for an in vivo effect of MF exposure which could be related to tumor promotion is reduction of circulating levels of melatonin, i.e. a hormone which is inhibitory to the growth of a wide range of cancers, particularly breast cancer. Animal studies have shown that 50-Hz MF exposure at flux densities as low as 0.3-1 m u Tesla significantly reduces nocturnal melatonin levels in plasma. Wh ile decrease of melatonin levels alone could explain tumor promoting o r co-promoting effect of MF exposure, recent data indicate that MF exp osure also impairs the effects of melatonin at the cellular level. Thu s, the oncostatic effect of melatonin on cell proliferation of a human breast cancer cell line was antagonized by 60-Hz MF exposure at a flu x density of about 1 mu Tesla. All these data indicate that interactio ns between 50/60-HZ MF exposure and melatonin may be the key mechanism of any carcinogenic effects. Although the existing experimental evide nce is still insufficient for discerning a cause-effect relationship f or MF exposure and human disease or injury, it does suggest the need f or further laboratory research under well-defined laboratory exposure conditions to allow for a realistic assessment of the possible health risks and their magnitude.